Point72 Asset Management L.P. Reduces Holdings in Humana Inc (NYSE:HUM)

Point72 Asset Management L.P. trimmed its position in shares of Humana Inc (NYSE:HUM) by 70.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 61,770 shares of the insurance provider’s stock after selling 144,321 shares during the quarter. Point72 Asset Management L.P.’s holdings in Humana were worth $22,640,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HUM. First Allied Advisory Services Inc. boosted its stake in shares of Humana by 3.7% during the fourth quarter. First Allied Advisory Services Inc. now owns 6,284 shares of the insurance provider’s stock valued at $2,305,000 after purchasing an additional 223 shares during the period. Harel Insurance Investments & Financial Services Ltd. increased its holdings in shares of Humana by 135.5% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 664 shares of the insurance provider’s stock valued at $243,000 after acquiring an additional 382 shares in the last quarter. National Pension Service increased its holdings in shares of Humana by 5.0% during the third quarter. National Pension Service now owns 163,520 shares of the insurance provider’s stock valued at $41,807,000 after acquiring an additional 7,730 shares in the last quarter. World Asset Management Inc increased its holdings in shares of Humana by 0.5% during the fourth quarter. World Asset Management Inc now owns 10,827 shares of the insurance provider’s stock valued at $3,968,000 after acquiring an additional 59 shares in the last quarter. Finally, Virtu Financial LLC increased its holdings in shares of Humana by 123.3% during the third quarter. Virtu Financial LLC now owns 3,823 shares of the insurance provider’s stock valued at $977,000 after acquiring an additional 2,111 shares in the last quarter. 94.02% of the stock is owned by institutional investors.

In other Humana news, Director David A. Jr/Ky Jones sold 5,800 shares of the firm’s stock in a transaction on Friday, March 20th. The stock was sold at an average price of $256.19, for a total value of $1,485,902.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.42% of the stock is owned by company insiders.

Several equities analysts have recently issued reports on the stock. Mizuho restated a “buy” rating and set a $405.00 price objective on shares of Humana in a report on Friday, February 14th. Goldman Sachs Group reiterated a “buy” rating and issued a $425.00 target price on shares of Humana in a research report on Monday, January 27th. Wells Fargo & Co reiterated an “overweight” rating and issued a $400.00 target price (up previously from $338.00) on shares of Humana in a research report on Wednesday, December 11th. Deutsche Bank upped their target price on Humana from $363.00 to $433.00 and gave the company a “hold” rating in a research report on Tuesday, February 18th. Finally, Morgan Stanley upped their target price on Humana from $457.00 to $460.00 and gave the company an “overweight” rating in a research report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $384.00.

NYSE HUM traded up $34.95 during mid-day trading on Wednesday, hitting $269.01. The stock had a trading volume of 3,028,953 shares, compared to its average volume of 1,548,075. The firm’s 50 day moving average is $331.10 and its 200 day moving average is $322.94. Humana Inc has a twelve month low of $208.25 and a twelve month high of $384.99. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.82 and a quick ratio of 1.82. The stock has a market capitalization of $28.33 billion, a price-to-earnings ratio of 13.40, a PEG ratio of 0.83 and a beta of 0.89.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $2.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.20 by $0.08. Humana had a return on equity of 20.89% and a net margin of 4.17%. The firm had revenue of $16.30 billion during the quarter, compared to the consensus estimate of $16.15 billion. During the same period in the prior year, the company earned $2.65 EPS. The firm’s revenue was up 15.0% compared to the same quarter last year. As a group, equities research analysts expect that Humana Inc will post 18.64 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a $0.625 dividend. The ex-dividend date of this dividend is Monday, March 30th. This is an increase from Humana’s previous quarterly dividend of $0.55. This represents a $2.50 dividend on an annualized basis and a dividend yield of 0.93%. Humana’s dividend payout ratio (DPR) is 12.31%.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading: What is a Swap?

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.